Pfizer Arthritis Pill Raises Safety Concerns, FDA Staff Says

Pfizer Inc.’s experimental pill to treat rheumatoid arthritis, one of the company’s leading drug candidates, raised “serious safety concerns” in trials, U.S. regulators said today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.